Baker Bros. Advisors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-495,113
| Closed | -$18.3M | – | 119 |
|
|
2022
Q3 | $18.3M | Hold |
495,113
| – | – | 0.12% | 50 |
|
|
2022
Q2 | $9.4M | Hold |
495,113
| – | – | 0.05% | 61 |
|
|
2022
Q1 | $13.4M | Hold |
495,113
| – | – | 0.08% | 58 |
|
|
2021
Q4 | $11.2M | Buy |
495,113
+294,117
| +146% | +$6.63M | 0.05% | 73 |
|
|
2021
Q3 | $5.27M | Buy |
200,996
+124,396
| +162% | +$3.26M | 0.02% | 93 |
|
|
2021
Q2 | $2.45M | Buy |
+76,600
| New | +$2.45M | 0.01% | 109 |
|